Stocks & Options
Trading Strategies
Institutional Holdings Directory
SEC Filings TLDR
Analysis Reports
AI Tools
EN
Sign in
GALECTIN THERAPEUTICS INC. Reports Q1 2026 Financial Results
2026-05-15
SEC Filing 10-Q
(0001140361-26-021495)
Please check the link below for details.
Ticker mentioned:
GALT
Source:
Original SEC Document β